The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 555-562

  De Feraudy, Sebastien ^a   Ridd, Katie ^a   Richards, Lauren M ^a,b   Kwok, Pui Yan ^a,b   Revet, Ingrid ^a   Oh, Dennis ^a,c   Feeney, Luzviminda ^a   Cleaver, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ARTICLE; CHROMOSOME 3P; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DNA DAMAGE; DNA SEQUENCE; GENE; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRIORITY JOURNAL; SERUM GROUP PI SYSTEM; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; WESTERN BLOTTING; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM GROUP C GENE;

EID: 77957270397     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090925     Document Type: Article

References (36)

1. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344:975-983
2. Rubin A, Chen E, Ratner D: Basal-cell carcinoma. N Engl J Med 2005, 353:2262-2269
3. Brantsch KD, Meisner C, Schönfisch B, Trilling, Wehner-Caroli J, Röcken M, Breuninger H: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008, 9:713-720
4. Bolshakov S, Walker C, Strom S, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN: p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 2003, 9:228-234 (Pubitemid 36109738)
5. Ridky TW, Khavari PA: Pathways sufficient to induce epidermal carcinogenesis. Cell Cycle 2004, 3:621-624
6. Ayli EE, Li W, Brown TT, Witkiewicz A, Elenitsas R, Seykora JT: Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders. J Cutan Pathol 2008, 35:273-277 (Pubitemid 351171253)
7. Cleaver JE: Defective repair replication in xeroderma pigmentosum. Nature 1968, 218:652-656
8. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ: Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer. McGraw-Hill, 1998, 245-274
9. Cleaver JE, Crowley E: UV damage. DNA repair and skin carcinogenesis. Front Biosci 2002, 7:d1024-d1043
10. Thompson LH: Nucleotide excision repair: Its relation to human disease. In: J. A. Nickoloff and M. Hoekstra (eds.), DNA Repair in Higher Eukaryotes, Vol. 2, Totowa, NJ: Humana Press, 1998, pp 335-393
11. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum:cutaneous, ocular and neurological abnormalities in 830 published cases. Arch Dermatol 1987, 123:241-250
12. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374
13. Brash DE, Rudolph JA, Simon JA, Lin GA, McKenna A, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: uV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88:10124-10128
14. Nataraj AJ, Trent JC, Ananthaswamy HN: p53 gene mutations and photocarcinogenesis. Photochem Photobiol 1995, 62:165-177
15. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L: Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993, 90:10529-10533
16. Cleaver JE: The biology of xeroderma pigmentosum: lessons learned to explain the development of melanoma. In: V. J. Hearing and S. P. L. Leong (eds.), Melanocytes to Melanoma: The Progression to Malignancy, Vol. 16: Humana Press, 2005
17. de Feraudy S, Boubakour-Azzouz I, Fraitag S, Berneburg M, Chan L, Chew K, Clericuzio CL, Cunningham B, Tope WD, Cleaver JE. Diagnosing xeroderma pigmentosum group C by immunohistochemistry. Am J Dermatopath 2010, 32:109-117
18. Snijders AM, Nowee ME, Fridlyand J, Piek, J.M. Dorsman, JC, Jain AN, Pinkel D, van Diest PJ, Verheijen RH, Albertson DG: Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene 2003, 22:4281-4286 (Pubitemid 36876248)
19. Curtin JA, Fridlyand J, Kageshita T, Patel, H.N. Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135-2147 (Pubitemid 41653105)
20. Gajduskova P, Snijders AM, Kwek S, Roydasgupta, R. Fridlyand J, Tokuyasu T, Pinkel D, Albertson DG: Genome position and gene amplification. Genome Biol 2007, 8:R120
21. Olshen AB, Venkatraman ES, Lucito R, Wigler M: Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5:557-572 (Pubitemid 41180205)
22. Willenbrock H, Fridlyand J: A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics 2005, 21:4084-4091 (Pubitemid 41672097)
23. Cleaver JE, Feeney L, Tang JY, Tuttle P: Xeroderma pigmentosum group C in an isolated region of Guatemala. J Invest Dermatol 2007, 127:493-496 (Pubitemid 46106931)
24. Cleaver JE, Afzal V, Feeney L, McDowell M, Sadinski W, Volpe JPG, Busch D, Yu Y, Nagasawa H, Little JB: Increased UV sensitivity and chromosomal instability related to p53 function in the xeroderma pigmentosum variant. Cancer Res 1999, 59:1102-1108 (Pubitemid 29135972)
25. Ford JM: Role of p53 in the mammalian cellular response to UV damage. Photochem Photobiol 1998, 67:73S-74S.
26. Ananthaswamy HN, Ouhtit A, Evans RL, Gorny A, Khaskina P, Sands AT, Conti CJ: Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis. Oncogene 1999, 18:7395-7398 (Pubitemid 30032122)
27. Burnworth B, Arendt S, Muffler S, Steinkraus, V. Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P: The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 2007, 86:763-780 (Pubitemid 350082194)
28. Clausen OP, Aass HC, Beigi M, Purdie KJ, Proby CM, Brown VL, Mattingsdal M, Micci F, Kolvraa S, Bolund L, Deangelis PM: Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 2006, 126:2308-2315 (Pubitemid 44413179)
29. Laposa RR, Feeney L, Crowley E, de Feraudy S, Cleaver JE: p53 suppression overwhelms DNA polymerase h deficiency in determining the cellular UV DNA damage response. DNA Repair 2007, 6:1794-1804
30. Ford JM, Hanawalt PC: Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J Biol Chem 1997, 272:28073-28080
31. Ford JM, Hanawalt PC: Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Nat Acad Sci USA 1995, 92:8876-8880
32. Bean GR, Bryson AD, Pilie PG, Goldenberg V, Baker JC Jr, Ibarra C, Brander DM, Paisie C, Case NR, Gauthier M, Reynolds PA, Dietze E, Ostrander J, Scott V, Wilke LG, Yee L, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Tlsty TD, Seewaldt VL: Morphologically normalappearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clin Cancer Res 2007, 13:6834-6841
33. Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A: p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res 1998, 58:4402-4409
34. Spatz A, Giglia-Mari G, Benhamou S, Sarasin A: Association between DNA repair-deficiency and high level of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res 2001, 61:2480-2486
35. Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S: Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogen 2005, 26:1085-1090 (Pubitemid 41214301)
36. Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Volkenandt M, Neumann C, Ziegler A, Kraemer KH, Reich K, Emmert S: No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Hum Genet 2005, 13:253-255 (Pubitemid 40220571)